Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis.

Regions where one type of epithelium replaces another (metaplasia) have a predilection for cancer formation. Environmental factors are closely linked to metaplastic carcinogenesis. In particular, cervical cancers associated with human papillomavirus (HPV) infection develop primarily at the transformation zone, a region where metaplastic squamous cells are detected in otherwise columnar epithelial-lined endocervical glands. Previously, we reported estrogen-induced multistage vaginal and cervical carcinogenesis in transgenic mice expressing HPV16 oncogenes in basal squamous epithelial cells. In the present study to investigate the threshold neoplastic response to exogenous estrogen, we treated groups of transgenic mice with lower hormone doses. A 5-fold reduction in estrogen dose induced squamous carcinogenesis solely at the cervical transformation zone compared with other reproductive tract sites. Further study delineated stages of transformation zone carcinogenesis, including formation of hyperplastic lower uterine glands and emergence of multiple foci of squamous metaplasia from individual stem-like glandular reserve cells, followed by neoplastic progression of metaplasia to dysplasia and squamous cancer. We propose that a combination of low-dose estrogen and low-level HPV oncogene expression biases transformation zone glandular reserve cells toward squamous rather than columnar epithelial fate decisions. Synergistic activation of proliferation by viral oncoprotein cell cycle dysregulation and estrogen receptor signaling, together with altered paracrine stromal-epithelial interactions, may conspire to support and promote neoplastic progression and cancer formation.

[1]  Tony Kouzarides,et al.  Retinoblastoma protein recruits histone deacetylase to repress transcription , 1998, Nature.

[2]  G. Vooijs.  The problem of replacement and differentiation of the intestinal epithelium , 1997, Cancer.

[3]  H. Bern,et al.  Cervicovaginal and mammary gland abnormalities in BALB/cCrgl mice treated neonatally with progesterone and estrogen, alone or in combination. , 1979, Cancer research.

[4]  J. Beilby.  Light Microscopic Techniques in Biology and Medicine , 1977 .

[5]  K. Korach,et al.  Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Wong,et al.  Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. , 1999, Gastroenterology.

[7]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[8]  A. Singer,et al.  The Process of Cervical Regeneration After Electrocauterization:Part 1. Histological and Colposcopic Study , 1967, The Australian & New Zealand journal of obstetrics & gynaecology.

[9]  A. Singer,et al.  The process of cervical regeneration after electrocauterization. II. Histochemical, autoradiographic and pH study. , 1967, The Australian & New Zealand journal of obstetrics & gynaecology.

[10]  D. Picard,et al.  Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. , 1996, The EMBO journal.

[11]  D. McCance,et al.  The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes , 1993, Journal of virology.

[12]  C. Woodworth,et al.  The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis , 1991, International journal of cancer.

[13]  M. Katovich,et al.  Effect of chronic estrogen on the skin temperature response to naloxone in morphine-dependent rats. , 1987, Canadian journal of physiology and pharmacology.

[14]  L. Magnaghi-Jaulin,et al.  Retinoblastoma protein represses transcription by recruiting a histone deacetylase , 1998, Nature.

[15]  E. Villiers.  Human Pathogenic Papillomavirus Types: An Update , 1994 .

[16]  D. Hanahan,et al.  Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice. , 1996, Oncogene.

[17]  S. Yuspa,et al.  FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. , 1993, Carcinogenesis.

[18]  H. Hausen.  Human papillomaviruses in the pathogenesis of anogenital cancer. , 1991 .

[19]  D. Bell,et al.  An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. , 1997, Cancer research.

[20]  J. Weissfeld,et al.  Etiology of Barrett's metaplasia and esophageal adenocarcinoma. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  B. O’Malley,et al.  An alternative ligand-independent pathway for activation of steroid receptors. , 1995, Recent progress in hormone research.

[22]  N. Weigel,et al.  Ligand-independent activation of steroid hormone receptors , 1998, Journal of Molecular Medicine.

[23]  D. Hanahan,et al.  Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. , 1997, Cancer research.

[24]  J M Ward,et al.  Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice. , 1999, Cancer research.

[25]  K. Korach.  Insights from the study of animals lacking functional estrogen receptor. , 1994, Science.

[26]  Lee M. Silver,et al.  Mouse Genetics: Concepts and Applications , 1995 .

[27]  L. Banks,et al.  Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Hanahan,et al.  Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Howley,et al.  The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Michael S. Pepper,et al.  The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth , 1994, Nature.

[31]  F. Smedts,et al.  Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia. , 1992, The American journal of pathology.

[32]  G. Demers,et al.  Cell cycle checkpoint control is bypassed by human papillomavirus oncogenes. , 1994, Cold Spring Harbor symposia on quantitative biology.

[33]  D. Hanahan,et al.  Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. , 1996, The American journal of pathology.

[34]  C. Glass,et al.  Coactivator and corepressor complexes in nuclear receptor function. , 1999, Current opinion in genetics & development.

[35]  D. Hanahan,et al.  Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice , 1994, Journal of virology.

[36]  D. Riethmacher,et al.  Factors controlling growth, motility, and morphogenesis of normal and malignant epithelial cells. , 1995, International review of cytology.

[37]  Q. Sun,et al.  In vitro and in vivo analysis of cellular origin of cervical squamous metaplasia. , 1993, The American journal of pathology.

[38]  E. Kuipers.  Review article: Relationship between Helicobacter pylori, atrophic gastritis and gastric cancer. , 1998, Alimentary pharmacology & therapeutics.

[39]  F. Talamantes,et al.  Cell proliferation and apoptosis during mammary carcinogenesis in pituitary isografted mice. , 1996, Carcinogenesis.

[40]  J. Fishman,et al.  Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[41]  E. Kuipers.  Relationship between Helicobacter pylori, atrophic gastritis and gastric cancer , 1998, Alimentary pharmacology & therapeutics.

[42]  W. Mooi,et al.  Keratin subtypes in carcinomas of the uterine cervix: implications for histogenesis and differential diagnosis. , 1990, Cancer research.

[43]  S. Chakrabarti,et al.  Localization of the sites of synthesis and action of insulin-like growth factor-I in the rat uterus. , 1990, Molecular endocrinology.

[44]  J. Freudenheim,et al.  Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. , 1998, Cancer research.

[45]  K. Münger,et al.  Functions of human papillomavirus proteins. , 1994, Current topics in microbiology and immunology.

[46]  J. Nevins,et al.  Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. , 1992, Proceedings of the National Academy of Sciences of the United States of America.